España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Pieris Pharmaceuticals
PIRS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.90
0.78
4.84%
Pre-Market: Nov 8, 8:00 AM EDT
Get Report
Comment
Pieris Pharmaceuticals (PIRS) Forecast
News
Earnings
Pieris Pharmaceuticals (PIRS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Pieris Pharmaceuticals (NASDAQ:PIRS) Stock
Pieris Pharmaceuticals Stock (NASDAQ: PIRS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Palvella Therapeutics Announces First Patient...
Benzinga Newsdesk
Thursday, October 03, 2024
Pieris Pharmaceuticals' Merger Partner Palvel...
Benzinga Newsdesk
Wednesday, July 24, 2024
Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
Avi Kapoor
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results
Avi Kapoor
Pieris Pharmaceuticals Shares Resume Trading
Benzinga Newsdesk
Pieris Pharmaceuticals Shares Halted On Circu...
Benzinga Newsdesk
Pieris Pharmaceuticals Shares Resume Trade
Benzinga Newsdesk
Pieris Pharmaceuticals Shares Halted On Circu...
Benzinga Newsdesk
Pieris Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Palvella Therapeutics And Pieris Pharmaceutic...
Benzinga Newsdesk
Thursday, May 16, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, May 09, 2024
Looking Into Pieris Pharmaceuticals's Recent Short Interest
Benzinga Insights
Pieris Pharmaceuticals Received Nasdaq Notice...
Benzinga Newsdesk
Tuesday, April 23, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Monday, April 22, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, April 18, 2024
Pieris Pharmaceuticals Announces 1-For-80 Rev...
Benzinga Newsdesk
Wednesday, March 27, 2024
Pieris Pharmaceuticals Announces Repositionin...
Benzinga Newsdesk
Wednesday, March 20, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, January 31, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, December 13, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, September 27, 2023
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Friday, August 25, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, August 24, 2023
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Thursday, August 17, 2023
Pieris Pharmaceuticals Has Achieved An Undisc...
Benzinga Newsdesk
Wednesday, August 16, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, July 24, 2023
Pieris Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/812,069 Titled "Muteins Of Human Lipocalin 2 With Affinity For A Given Target (For The Diagnosis And Treatment Of Tumor Diseases)"
Happy Mohamed
Tuesday, July 18, 2023
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Pieris Pharmaceuticals Shares Shooting Higher Today?
Vandana Singh
Pieris Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Pieris Pharmaceuticals Shares Resume Trade
Happy Mohamed
Pieris Pharma Shares To Resume Trade At 9:50 ...
Happy Mohamed
Pieris Pharmaceuticals Provides Strategic Update And Announces Restructuring; As Part Of Its Cash Preservation Plan, Pieris Initiated A Corporate Restructuring That Will Result In A Reduction Of The Company's Workforce By ~70%
Happy Mohamed
Pieris Pharmaceuticals Shares Halted, News Pe...
Benzinga Newsdesk
Monday, June 26, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Friday, June 23, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Thursday, June 22, 2023
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Wednesday, June 21, 2023
Why Are Pieris Pharmaceuticals Shares Tanking Today
Vandana Singh
Pieris shares are trading lower after AstraZe...
Benzinga Newsdesk
Pieris Pharma Shares To Resume Trade At 7:30 ...
Charles Gross
Pieris Reports AstraZeneca Discontinuation Of...
Benzinga Newsdesk
Pieris Pharmaceuticals Halted; Pending News
Charles Gross
Wednesday, May 31, 2023
Pieris Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Pieris Pharmaceuticals Granted EU Patent #3322433 Today For "Novel Proteins Specific For Lag-3 (Anti-tumor Response For Cancer)"
Happy Mohamed
Monday, May 22, 2023
Pieris Pharmaceuticals Announces Presentation...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch